ZINGONE, FABIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.253
AS - Asia 745
EU - Europa 728
OC - Oceania 14
SA - Sud America 10
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.757
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.245
SG - Singapore 344
IT - Italia 332
CN - Cina 306
FR - Francia 82
FI - Finlandia 76
DE - Germania 58
GB - Regno Unito 58
SE - Svezia 29
IE - Irlanda 22
IN - India 20
VN - Vietnam 20
PH - Filippine 12
AU - Australia 11
RO - Romania 9
UA - Ucraina 9
NL - Olanda 8
JP - Giappone 7
BR - Brasile 6
IR - Iran 6
CA - Canada 5
ES - Italia 5
HK - Hong Kong 5
MK - Macedonia 5
NO - Norvegia 5
PK - Pakistan 5
CH - Svizzera 4
EG - Egitto 4
IQ - Iraq 4
RU - Federazione Russa 4
AT - Austria 3
BD - Bangladesh 3
BG - Bulgaria 3
DK - Danimarca 3
ID - Indonesia 3
IL - Israele 3
NZ - Nuova Zelanda 3
PL - Polonia 3
CL - Cile 2
CZ - Repubblica Ceca 2
DM - Dominica 2
LS - Lesotho 2
MD - Moldavia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BE - Belgio 1
BY - Bielorussia 1
GR - Grecia 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
NP - Nepal 1
SA - Arabia Saudita 1
Totale 7.757
Salva come PNG Salva come JPEG
Città #
Fairfield 1.489
Woodbridge 563
Ashburn 529
Houston 485
Seattle 484
Cambridge 465
Wilmington 360
Chandler 344
Singapore 255
Ann Arbor 207
San Diego 186
Medford 144
Princeton 144
Des Moines 105
Beijing 84
Padova 81
Helsinki 66
Roxbury 66
Santa Clara 46
Guangzhou 43
Nanjing 43
Milan 31
Dong Ket 16
Dublin 16
London 15
Shanghai 15
Shenyang 15
Nanchang 14
Boardman 12
Hangzhou 11
Lappeenranta 10
Ogden 10
Rome 10
Norwalk 9
San Martino Buon Albergo 9
Hebei 8
Jiaxing 7
Parma 7
Pune 7
Kilburn 6
Paris 6
Rockville 6
Arezzo 5
Chicago 5
Curtarolo 5
Frankfurt am Main 5
Hounslow 5
Jinan 5
Karachi 5
Manila 5
Menlo Park 5
New York 5
Santorso 5
Skopje 5
Washington 5
Baghdad 4
Chiswick 4
Florence 4
Genoa 4
Kharkiv 4
Lanzhou 4
Palermo 4
Prescot 4
Tianjin 4
Trollhättan 4
Venice 4
Acton 3
Amalapuram 3
Amsterdam 3
Andover 3
Borås 3
Cairo 3
Council Bluffs 3
Deiva Marina 3
Duino-Aurisina 3
Hanoi 3
Hong Kong 3
Hyderabad 3
Kish 3
Las Vegas 3
Los Angeles 3
Phoenix 3
Redmond 3
São Paulo 3
Taiyuan 3
Trapani 3
Verona 3
Vienna 3
Aversa 2
Bari 2
Bassano del Grappa 2
Bratislava 2
Brierley Hill 2
Buffalo 2
Cagliari 2
Campi Bisenzio 2
Catania 2
Cernusco sul Naviglio 2
Changsha 2
Chisinau 2
Totale 6.628
Salva come PNG Salva come JPEG
Nome #
Risk of bacterial pneumonia and pneumococcal infection in youths with celiac disease — A population-based study 143
Prevalence and correlates of Benign Pancreatic Hyperenzymemia in a large general population sample: The Damocles sword perception 117
Anhedonia in irritable bowel syndrome and in inflammatory bowel diseases and its relationship with abdominal pain 115
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 110
Appetite and gastrointestinal hormone response to a gluten-free meal in patients with coeliac disease 105
Same-day regimen as an alternative to split preparation for colonoscopy: A systematic review with meta-analysis 98
The risk of community-acquired pneumonia among 9803 patients with coeliac disease compared to the general population: a cohort study 97
REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY 93
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. 89
Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab 87
Coeliac disease in the elderly in a tertiary centre 83
Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents. 82
Dietary gluten and the development of celiac disease and type 1 diabetes 82
Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis 82
Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients 82
Factors associated with disability in patients with ulcerative colitis: A cross-sectional study 81
The Oslo definitions for coeliac disease and related terms. 79
The celiac disease patients' ability to experience pleasure 78
Duodenal Histological Findings and Risk of Coeliac Disease in Subjects with Autoimmune Atrophic Gastritis: A Retrospective Evaluation 78
The culture of gut explants: A model to study the mucosal response 77
Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital 76
The risk of epilepsy in children with celiac disease: a population-based cohort study 75
Factors Predicting the Adherence to the Therapy of Italian IBD Patients 74
Coeliac disease: factors affecting the transition and a practical tool for the transition to adult healthcare 73
Alterations in Diets of Patients with Non-celiac Gluten Sensitivity Compared to Healthy Individuals 73
A survey on nutritional knowledge in coeliac disease compared to inflammatory bowel diseases patients and healthy subjects 71
Gliadin Does Not Induce Mucosal Inflammation or Basophil Activation in Patients with Non-Celiac Gluten Sensitivity. 70
Psoriasis in a nationwide cohort study of patients with celiac disease 70
Body mass index and prevalence of skin diseases in adults with untreated coeliac disease 68
25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D, and Peripheral Bone Densitometry in Adults with Celiac Disease 68
High risk of lower urinary tract symptoms in patients with irritable bowel syndrome 67
Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak 67
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach 67
Socioeconomic variation in the incidence of childhood coeliac disease in the UK. 66
Perinatal and antibiotic exposures and the risk of developing childhood-onset inflammatory bowel disease: A nested case-control study based on a population-based birth cohort 66
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study 65
With antitransglutaminase antibodies in the breast milk, is breastfeeding beneficial or harmful? 64
The quality of sleep in patients with coeliac disease 63
Risk of complications in coeliac patients depends on age at diagnosis and type of clinical presentation 63
Non-polypoid colorectal neoplasms: Characteristics and endoscopic management 63
In Vitro Gliadin Challenge: Diagnostic Accuracy and Utility for the Difficult Diagnosis of Celiac Disease. 62
The Psychosocial Burden of HCV Infection and the Impact of Antiviral Therapy on the Quality of Life in Liver and Kidney Transplant Recipients: A Pilot Study 61
Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak 61
Perception of the COVID-19 pandemic among patients with inflammatory bowel disease in the time of telemedicine: cross-sectional questionnaire study 60
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator 60
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study 60
PROgnosticating COeliac patieNts SUrvivaL: The PROCONSUL Score. 59
'For a quart of ale is a dish for a king': not always 59
Urinary Stone Disease in Adults With Celiac Disease: Prevalence, Incidence and Urinary Determinants 58
Psychological morbidity of celiac disease: A review of the literature 57
Tooth wear is frequent in adult patients with celiac disease 57
The value and significance of 25(OH) and 1,25(OH) vitamin D serum levels in adult coeliac patients: A review of the literature 57
Inflammatory Bowel Disease and Sleep Disturbance: As Usual, Quality Matters 57
Effects of SARS-CoV-2 emergency measures on high-risk lesions detection: a multicentre cross-sectional study 57
Clinical features and psychological impact of celiac disease at diagnosis 57
Increased risk of epilepsy in biopsy-verified celiac disease: a population-based cohort study. 56
Low incidence but poor prognosis of complicated coeliac disease: A retrospective multicentre study. 56
Outcomes of COVID-19 in 79 patients with IBD in Italy: An IG-IBD study 56
The coeliac stomach: A review of the literature 55
Celiac disease: Alternatives to a gluten free diet. 54
Human leukocyte antigen DQ2/8 prevalence in non-celiac patients with gastrointestinal diseases. 54
The Lyon Consensus: Does it differ from the previous ones? 54
Dietary management of eosinophilic esophagitis: Tailoring the approach 54
Lack of Clinical Relevance of ANA and ASMA Positivity in Patients with Liver Transplantation without a History of Autoimmune Diseases 53
Buccal localization of Crohn’s disease with long-term infliximab therapy: a case report 53
Prevalence of sleep bruxism in ibd patients and its correlation to other dental disorders and quality of life 53
Medical and gastroenterological education during the COVID-19 outbreak 53
Telemedicine in the COVID-19 era for Liver Transplant Recipients: an Italian lockdown area experience 53
Latest insights into the hot question of proton pump inhibitor safety – a narrative review 53
No need of transforming gastroenterology units to covid units at the time of SARS-COV2 infection - a single-center analysis from northern italy 52
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology 51
Screening for celiac disease in the general population and in high-risk groups 51
Early Prediction of Cardiovascular Disease in Kidney Transplant Recipients 51
Sleep disturbance in Inflammatory Bowel Disease: prevalence and risk factors – A cross-sectional study 51
Vonoprazan fumarate for the treatment of gastric ulcers: A short review on emerging data 51
Population-based dose-response curve of glomerular filtration rate to dietary protein intake 50
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis 50
Incidence and distribution of coeliac disease in Campania (Italy): 2011-2013 49
HLA DQ2/8 Prevalence in Non-Celiac Patients With Gastrointestinal Diseases 49
PTU-151 Risk of community-acquired pneumonia among patients with coeliac disease compared to the general population: a population based cohort study: Abstract PTU-151 Table 1 49
Life Events and the Onset of Celiac Disease from a Patient’s Perspective 49
Erythrocytosis after liver transplantation: The experience of a university hospital 48
An un common case of gluten sensitivity 48
Prevalence of eating disorders in adults with celiac disease. 47
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 47
Good efficacy and safety of vedolizumab in Crohn’s disease and ulcerative colitis in a real-world scenario 47
The risk of malignancies in celiac disease—A literature review 47
The Italian translation of the Celiac Disease-specific Quality of Life Scale in celiac patients on gluten free diet 46
Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre 45
Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 45
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders 44
Moderately increased risk of urinary stone disease in patients with biopsy-verified coeliac disease 43
Autoimmune Atrophic Gastritis: The Role of miRNA in Relation to Helicobacter Pylori Infection 42
Risk of acute appendicitis in and around pregnancy a population-based cohort study from England 42
Quality-of-life evaluation in Coeliac patients on a gluten-free diet 42
Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak 42
Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice 42
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study 42
Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies 41
Risk of COVID-19 in celiac disease patients 41
Totale 6.310
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.987
article - articoli 37.625
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 436
Totale 77.048
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.273 0 0 23 208 139 87 130 157 197 162 117 53
2020/20211.516 97 79 117 50 34 237 108 126 226 136 117 189
2021/20222.074 95 228 220 170 90 158 129 187 122 79 129 467
2022/2023867 246 62 38 78 120 104 9 51 83 5 47 24
2023/2024832 31 77 88 66 46 65 64 50 74 29 100 142
2024/2025489 18 289 182 0 0 0 0 0 0 0 0 0
Totale 7.927